Wound Management Technologies Responds to SEC Complaint
The SEC charged former Wound Management Technologies chairman, president & CEO Scott Haire of using kickbacks to “illegally generate stock sales.”
14471
Wound Management Sells Non-Core Subsidiary; Intends to Focus on CellerateRX and Medical Device Business
In total, over $500,000 in debt was removed from the balance sheet of Wound Management.
WNDM to Acquire Medical Device Distributor Juventas; Bryant Gaines Named WNDM COO Effective Immediately
Wound Management Technologies, Inc. has signed a letter of intent to acquire Juventus LLC. which operates a nationwide distributor network.
Wound Management Activates Orthopedic Business; Partner Chosen to Develop Products Based on its Patent
Wound Management announced that its subsidiary, Resorbable Orthopedic Products has entered into an agreement with BioStructures.
Wound Management Proves Strong Potential With Distribution Agreements In Place
OneMedRadio interviewed President and Director Deborah Jenkins Hutchinson and got a glimpse into this emerging growth company.
Wound Management Technologies Inks Distribution Deal Worth Initial $2M
Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, recently announced a major distribution deal with Marketing Media Enterprises.
Wound Management Technologies Addresses Multi Billion Dollar Wound Care Market With CellerateRX
Wound Management’s FDA approved product has become a primary treatment for all types of wounds and sparked interest in the investment community.